A San Diego biotech firm hopes Neffy, a nasal spray to counter severe allergic reactions, will encourage those fearing injections to treat anaphylaxis sooner.
Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...
A recent study published in Genomic Psychiatry has unveiled a promising new therapy that may help improve memory and reduce ...
Epinephrine nasal spray may encourage patients suffering a severe allergic reaction not delay treatment in an emergency.
GSK announced positive results from two phase 3 clinical trials evaluating its experimental drug, depemokimab, for chronic rhinosinusitis with nasal polyps affecting 4% of the population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback